Skip to main content

Seed · 2026-11-03 · Healthcare

Vitroscope raises $7.0M

58
AI Score
Amount
$7.0M
Round
Seed
Lead
Cerberus Ventures, YZR Capital
HQ
—
Why it matters: Vitroscope's perfusion platform keeps living tissue viable for days, and the round funds a 96-experiment version aimed at producing longitudinal drug-discovery data.

Vitroscope raised $7 million, a $5 million seed round co-led by Cerberus Ventures and YZR Capital plus $2 million in non-dilutive funding from the Research Council of Norway.

Participants:
Arcas Ventures, Golden Egg Check, Devico Invest, Carles Reina, Fàtima Godall, Oskari Pétas, The Research Council of Norway

Deal Dossier PRO

Pro feature
Deal Dossier for Vitroscope

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing